Why the study?
Does DAH30 have construct validity as a patient-centered outcome measure after surgery?
Does DAH30 have construct validity as a patient-centered outcome measure after surgery?
DAH30 is a valid and pragmatic patient-centered outcome measure for perioperative clinical trials.
May support DAH30 adoption in perioperative trials; extends validation evidence but leaves open RCT confirmation.
DAH₃₀ has construct validity and is a readily obtainable generic patient-centred outcome measure. It is a pragmatic outcome measure for perioperative clinical trials.
No takes yet. Share an insight, caveat, or question.
Myles et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: